MAM
PTCT icon

Meeder Asset Management’s PTC Therapeutics PTCT Stock Holding History

Meeder Asset Management’s Portfolio PTCT Stock Details PTCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-1,739
Closed -$65K – 2050
2021
Q3 		$65K Buy
1,739
+1,273
+273% +$52.3K ﹤0.01% 1020
2021
Q2 		$20K Buy
+466
New +$20K ﹤0.01% 1461
2020
Q3 		– Sell
-3,655
Closed -$185K – 2334
2020
Q2 		$185K Buy
3,655
+1,627
+80% +$79.9K 0.01% 619
2020
Q1 		$89K Sell
2,028
-3,701
-65% -$186K 0.01% 745
2019
Q4 		$275K Buy
5,729
+3,991
+230% +$170K 0.02% 517
2019
Q3 		$60K Buy
1,738
+1,667
+2,348% +$72.6K ﹤0.01% 952
2019
Q2 		$3K Buy
+71
New +$2.8K ﹤0.01% 1802
2019
Q1 		– Sell
-1,068
Closed -$37K – 1817
2018
Q4 		$37K Buy
1,068
+89
+9% +$3.2K ﹤0.01% 892
2018
Q3 		$47K Sell
979
-3,073
-76% -$127K ﹤0.01% 795
2018
Q2 		$137K Buy
+4,052
New +$126K 0.01% 570
2018
Q1 		– Sell
-430
Closed -$8K – 1709
2017
Q4 		$8K Buy
430
+47
+12% +$796 ﹤0.01% 1196
2017
Q3 		$8K Buy
383
+334
+682% +$6.54K ﹤0.01% 1134
2017
Q2 		$1K Sell
49
-109
-69% -$1.47K ﹤0.01% 1541
2017
Q1 		$2K Sell
158
-1,983
-93% -$24K ﹤0.01% 1394
2016
Q4 		$24K Sell
2,141
-2,444
-53% -$25.6K ﹤0.01% 630
2016
Q3 		$64K Sell
4,585
-7,598
-62% -$61.8K 0.01% 633
2016
Q2 		$86K Buy
+12,183
New +$89.4K 0.01% 679
2016
Q1 		– Sell
-678
Closed -$22K – 903
2015
Q4 		$22K Buy
+678
New +$20K ﹤0.01% 736

Other funds holding PTCT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Meeder Asset Management's PTCT Position: Q4 2021 in Review

Meeder Asset Management sold out of PTC Therapeutics (PTCT) in Q4 2021, closing a stake of 1,739 shares — an estimated $65K sold.

Meeder Asset Management first reported a position in PTCT in Q4 2015 and held it in 18 quarters. The position peaked at $275K in Q4 2019. 178 funds tracked by Wall St. Rank hold PTCT as of Q4 2021.

  • Meeder Asset Management reported no remaining PTC Therapeutics position as of Q4 2021 after selling out during the quarter.
  • Meeder Asset Management sold 1,739 PTC Therapeutics shares in Q4 2021, an estimated $65K.
  • Meeder Asset Management first reported a position in PTC Therapeutics in Q4 2015 and held it in 18 quarters.
  • Meeder Asset Management's PTC Therapeutics position peaked at $275K in Q4 2019.
  • 178 funds tracked by Wall St. Rank held PTC Therapeutics as of Q4 2021.

Based on Meeder Asset Management's 13F filing for Q4 2021, filed 11 Feb 2022.